ReviewPhytotherapy research : PTR2025
Potential Therapeutic Actions of Flavonoids Present in Propolis That Modulate Vascular Endothelial Growth Factor Signaling to Regulate Angiogenesis.
Review in Phytotherapy research : PTR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Kaempferol's Therapeutic Applications and Mechanistic Insights in Ocular Diseases: Current Progress, Challenges, and Translational Opportunities.Pharmaceutics · 2026Review
- Potential Effects of Bee Products Against Hantavirus Infection: Potential Mechanisms of Action and Future Directions.Life (Basel, Switzerland) · 2026Review
- Wound-Healing Efficacy ofFood science & nutrition · 2026Article
- Yinzhilan Formula Ameliorates Healing Delay in Diabetic Ulcer by Inhibiting PARP1 Activation and Regulating Macrophage Polarization.Current pharmaceutical design · 2026Article
- Potential Therapeutic Actions of Flavonoids Present in Propolis That Modulate Vascular Endothelial Growth Factor Signaling to Regulate Angiogenesis.Phytotherapy research : PTR · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Propolis is a plant-derived substance collected by honeybees that has a range of potential therapeutic applications. Propolis consists of resins, waxes, and fatty acids, as well as essential oils and other organic compounds. The pharmacologically active components of propolis include phenols and flavonoids, among others. Flavonoids that are found in propolis include chrysin, quercetin, galangin, kaempferol, and apigenin. Angiogenesis is the growth of new blood vessels from endothelial cell precursors. Angiogenesis is important in normal physiology and development. Pathological angiogenesis is widely implicated in human diseases, such as retinal diseases, cancers, and inflammatory diseases; currently, many of these conditions lack effective treatments. The process of angiogenesis is modulated by pro-angiogenic factors, in particular, Vascular Endothelial Growth Factor (VEGF). Flavonoids, including several that are present in propolis, have been found to inhibit angiogenesis by attenuating VEGF signaling. Although promising, such findings are primarily based on preclinical studies, and few clinical studies have evaluated the efficacy and toxicity of flavonoids in vivo. This review outlines the therapeutic potential of essential flavonoids from propolis that may have value as anti-angiogenic agents by modulating VEGF signaling. Overall, the findings suggest that flavonoids that are present in propolis are potential agents for the treatment of human diseases in which pathological angiogenesis is activated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.